These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 27977596)

  • 21. Efficacy and safety of bevacizumab plus erlotinib versus bevacizumab or erlotinib alone in the treatment of non-small-cell lung cancer: a systematic review and meta-analysis.
    Zhang S; Mao XD; Wang HT; Cai F; Xu J
    BMJ Open; 2016 Jun; 6(6):e011714. PubMed ID: 27363819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-EGFR monoclonal antibody plus chemotherapy for treating advanced non-small cell lung cancer: A meta-analysis.
    Luo W; Li Y; Ye F; Li Q; Zhang G; Li J; Li X
    Medicine (Baltimore); 2021 Nov; 100(47):e27954. PubMed ID: 34964780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes.
    Le Chevalier T; Scagliotti G; Natale R; Danson S; Rosell R; Stahel R; Thomas P; Rudd RM; Vansteenkiste J; Thatcher N; Manegold C; Pujol JL; van Zandwijk N; Gridelli C; van Meerbeeck JP; Crino L; Brown A; Fitzgerald P; Aristides M; Schiller JH
    Lung Cancer; 2005 Jan; 47(1):69-80. PubMed ID: 15603856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A randomized, controlled, multicenter clinical trial comparing pemetrexed/cisplatin and gemcitabine/cisplatin as first-line treatment for advanced nonsquamous non-small cell lung cancer].
    Huang Y; Liu Y; Zhou J; Xu N; Li B; Wu G; Fang J; Li K; Liu X; Liu W; Lu Y; Wang M; Liu W; Liang H; Zhang Y; Huang C; Wang S; Wang Y; Yu S; Chang J; Wang Z; Hu Z; Zhang L
    Zhongguo Fei Ai Za Zhi; 2012 Oct; 15(10):576-82. PubMed ID: 23075681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Xiao-ai-ping injection adjunct with platinum-based chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis.
    Feng F; Huang J; Wang Z; Zhang J; Han D; Wu Q; He H; Zhou X
    BMC Complement Med Ther; 2020 Jan; 20(1):3. PubMed ID: 32020869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety profile of combining agents against epidermal growth factor receptor or vascular endothelium growth factor receptor with gemcitabine-based chemotherapy in patients with advanced pancreatic cancer: a meta-analysis.
    Tian W; Ding W; Kim S; Xu X; Pan M; Chen S
    Pancreatology; 2013; 13(4):415-22. PubMed ID: 23890141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aidi injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A meta-analysis of 42 RCTs following the PRISMA guidelines.
    Wang J; Li G; Yu L; Mo T; Wu Q; Zhou Z
    J Ethnopharmacol; 2018 Jul; 221():137-150. PubMed ID: 29655852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pemetrexed plus platinum as the first-line treatment option for advanced non-small cell lung cancer: a meta-analysis of randomized controlled trials.
    Li M; Zhang Q; Fu P; Li P; Peng A; Zhang G; Song X; Tan M; Li X; Liu Y; Wu Y; Fan S; Wang C
    PLoS One; 2012; 7(5):e37229. PubMed ID: 22615946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients: a minnie pearl cancer research network phase II trial.
    Hainsworth JD; Burris HA; Litchy S; Erland JB; Hon JK; Brierre JE; Greco FA
    Cancer; 2000 Mar; 88(6):1353-8. PubMed ID: 10717616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A meta-analysis of pemetrexed plus platinum chemotherapy versus gemcitabine plus platinum chemotherapy for advanced non-small cell lung cancer].
    Jiang J; Li L; Wang X; Tian J; Wang Q; Lin Q
    Zhongguo Fei Ai Za Zhi; 2011 Jan; 14(1):43-8. PubMed ID: 21219831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erlotinib-based targeted dual agent versus erlotinib alone in previously treated advanced non-small-cell lung cancer: a meta-analysis of 13 randomized controlled trials.
    Yu S; Xu Q; Yuan Y; Li X; Cai H
    Curr Med Res Opin; 2016 Dec; 32(12):1927-1934. PubMed ID: 27479336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of gemcitabine or pemetrexed in combination with a platinum in patients with non-small-cell lung cancer and prior interstitial lung disease.
    Choi MK; Hong JY; Chang W; Kim M; Kim S; Jung HA; Lee SJ; Park S; Chung MP; Sun JM; Park K; Ahn MJ; Ahn JS
    Cancer Chemother Pharmacol; 2014 Jun; 73(6):1217-25. PubMed ID: 24696125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fixed-dose rate infusion and standard rate infusion of gemcitabine in patients with advanced non-small-cell lung cancer: a meta-analysis of six trials.
    Qiu MT; Ding XX; Hu JW; Tian HY; Yin R; Xu L
    Cancer Chemother Pharmacol; 2012 Dec; 70(6):861-73. PubMed ID: 23053260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence of Astragalus injection combined platinum-based chemotherapy in advanced nonsmall cell lung cancer patients: A systematic review and meta-analysis.
    Cao A; He H; Wang Q; Li L; An Y; Zhou X
    Medicine (Baltimore); 2019 Mar; 98(11):e14798. PubMed ID: 30882655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gemcitabine-induced thrombocytosis as a potential predictive factor in non-small cell lung cancer: analysis of 318 patients.
    Canova S; Cicchiello F; Agustoni F; Bianchini G; Abbate MI; Bidoli P; Cortinovis DL
    Tumori; 2017 Mar; 103(2):143-147. PubMed ID: 28009425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis on resected pancreatic cancer: a comparison between adjuvant treatments and gemcitabine alone.
    Chen H; He R; Shi X; Zhou M; Zhao C; Zhang H; Qin R
    BMC Cancer; 2018 Oct; 18(1):1034. PubMed ID: 30352573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy plus multitargeted antiangiogenic tyrosine kinase inhibitors or chemotherapy alone in advanced NSCLC: a meta-analysis of randomized controlled trials.
    Xiao YY; Zhan P; Yuan DM; Liu HB; Lv TF; Song Y; Shi Y
    Eur J Clin Pharmacol; 2013 Feb; 69(2):151-9. PubMed ID: 22729611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer.
    Sandler AB; Nemunaitis J; Denham C; von Pawel J; Cormier Y; Gatzemeier U; Mattson K; Manegold C; Palmer MC; Gregor A; Nguyen B; Niyikiza C; Einhorn LH
    J Clin Oncol; 2000 Jan; 18(1):122-30. PubMed ID: 10623702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intercalated Combination of Chemotherapy and EGFR-TKIs versus Chemotherapy Alone in the First-line Treatment of Advanced Non-small Cell Lung Cancer: A Meta-analysis].
    Hong C; Mei T; Wang J
    Zhongguo Fei Ai Za Zhi; 2016 Dec; 19(12):837-846. PubMed ID: 27978869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of gemcitabine-based chemotherapy in metastatic breast cancer: a meta-analysis of randomized controlled trials.
    Li W; Wang H; Li X
    Curr Med Res Opin; 2013 Nov; 29(11):1443-52. PubMed ID: 23927481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.